Business News

Gland Pharma rallies 12%, stock hits 4-year high post Q1 results

FinSiddhi

Gland Pharma Share: The market price of Gland Pharma hit a high of ₹2,989.2 in intra-day deals on Tuesday. The stock bounced back 90 per cent from its 52-week low of ₹1,575 touched on March 16, 2026.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Using pick-up and drop for car service? Know who pays if an accident happens

Service centres cannot evade responsibility for accidents during vehicle pick-up and drop-off. A signed waiver does not absolve them of negligence or deficient service. Insurance companies may still cover claims, then recover costs from the negligent party. Dealers face direct liability, while manufacturers’ responsibility is less automatic. Damage within service centre premises shifts significant legal…

Canadian billionaire Kevin O’Leary says that Wall Street is booming, but that is may not shape 2026 elections, here’s what is likely to

Canadian billionaire Kevin O’Leary highlights a troubling gap between robust economic performance and the struggle for household affordability. He emphasizes that soaring energy prices are poised to sway upcoming elections and public opinion. Additionally, O’Leary anticipates a surge in economic collaboration among the U.S., Canada, and Mexico, driven by shared concerns about China’s expanding technological…

ED launches probe into Jharkhand recruitment exams amid student protests

<a href=”https://timesofindia.indiatimes.com/india/ed-launches-probe-into-jharkhand-recruitment-exams-amid-student-protests/articleshow/133087270.cms”><img border=”0″ hspace=”10″ align=”left” style=”margin-top:3px;margin-right:5px;” src=”https://timesofindia.indiatimes.com/photo/133087270.cms” /></a>